SIRT2 and Huntington disease: Genetic or pharmacologic SIRT2 inhibition reduced sterol levels via decreased nuclear SREBP-2 trafficking and showed neuroprotective effect in a striatal neuron model of HD (Luthi-Carter et al., 2010).